# Early Administration of Norepinephrine in Sepsis

> **NCT05836272** · PHASE4 · RECRUITING · sponsor: **Tunis University** · enrollment: 200 (estimated)

## Conditions studied

- Sepsis, Severe

## Interventions

- **DRUG:** Norepinephrine Bitartrate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05836272
- **Lead sponsor:** Tunis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05836272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05836272, "Early Administration of Norepinephrine in Sepsis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05836272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*